AGNG vs. IBB
Compare and contrast key facts about Global X Aging Population ETF (AGNG) and iShares Nasdaq Biotechnology ETF (IBB).
AGNG and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. AGNG is a passively managed fund by Global X that tracks the performance of the Indxx Aging Population Thematic Index. It was launched on May 9, 2016. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. Both AGNG and IBB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AGNG or IBB.
Key characteristics
| AGNG | IBB | |
|---|---|---|
| YTD Return | 0.49% | -7.41% |
| 1Y Return | 3.33% | -2.08% |
| 3Y Return (Ann) | -0.22% | -7.16% |
| 5Y Return (Ann) | 7.41% | 3.47% |
| Sharpe Ratio | 0.22 | -0.21 |
| Daily Std Dev | 12.03% | 16.54% |
| Max Drawdown | -30.58% | -62.85% |
| Current Drawdown | -6.55% | -28.11% |
Correlation
The correlation between AGNG and IBB is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
AGNG vs. IBB - Performance Comparison
In the year-to-date period, AGNG achieves a 0.49% return, which is significantly higher than IBB's -7.41% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
AGNG vs. IBB - Expense Ratio Comparison
AGNG has a 0.50% expense ratio, which is higher than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
AGNG vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Aging Population ETF (AGNG) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AGNG vs. IBB - Dividend Comparison
AGNG's dividend yield for the trailing twelve months is around 0.96%, more than IBB's 0.33% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGNG Global X Aging Population ETF | 0.96% | 0.96% | 0.49% | 0.72% | 0.36% | 0.84% | 1.00% | 1.03% | 1.05% | 0.00% | 0.00% | 0.00% |
IBB iShares Nasdaq Biotechnology ETF | 0.33% | 0.26% | 0.31% | 0.21% | 0.21% | 0.17% | 0.20% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
AGNG vs. IBB - Drawdown Comparison
The maximum AGNG drawdown since its inception was -30.58%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for AGNG and IBB. For additional features, visit the drawdowns tool.
Volatility
AGNG vs. IBB - Volatility Comparison
The current volatility for Global X Aging Population ETF (AGNG) is 4.07%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 5.24%. This indicates that AGNG experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.